China Food

Huaxi biology acquired 51% equity of Yierkang biology and officially entered the collagen industry


Yierkang biology is located in the national new media industry base in Daxing District, Beijing. It is a national high-tech enterprise with 17 registered patents and 78 on-the-job employees. The company has been deeply engaged in collagen medical end products for many years. Its main products are collagen sponge and artificial bone.
After more than 20 years of development, Yierkang biology has realized the whole chain layout from R & D, production to sales. It is a high-tech biotechnology enterprise with complete qualifications, good assets and orderly organization. At present, the company is in good operating condition. In 2019, 2020 and January November 2021, the company achieved revenue of 87.2525 million yuan, 79.2855 million yuan and 75.6798 million yuan respectively; The net profit is 24.8065 million yuan, 10.9706 million yuan and 13.0914 million yuan. As of November 30, 2021, the total assets of the company are 113 million yuan.
As a world-renowned biotechnology company and bioactive material company, Huaxi biology mainly focuses on the development and industrial application of bioactive substances conducive to life and health, such as functional sugars, proteins, peptides, amino acids, nucleotides and natural active compounds. Among them, in the field of hyaluronic acid, Huaxi biology is currently the world’s largest R & D, production and sales enterprise of hyaluronic acid, accounting for 43% of the global market share of hyaluronic acid.
collagen and hyaluronic acid are important substances widely distributed in the human body. They are biological materials with a wide range of applications, including medical and health care, skin care products, food and so on.
after the equity acquisition, Yierkang biology will become the holding subsidiary of Huaxi biology. The company will actively carry out business integration and coordinated development with Yierkang biology to enhance the market competitiveness and sustainable development ability of Yierkang biology.
In addition, collagen will become another core material of Huaxi biology, enrich the company’s bioactive product pipeline, and play a strong support for the sustainable development of the company’s future business. The hospital admission products such as collagen sponge and artificial bone mainly produced by Yierkang biology can further enrich the company’s existing medical terminal product pipeline, form a good medical terminal product matrix and multi department layout.
source: Huaxi Biotechnology (ID: bloomagebiotech), reprint has been authorized. Reprint authorization and media business cooperation: Amy (wechat: 13701559246); Foodaily Expo 2022] in line with the original intention of providing the whole value chain and one-stop industrial innovation services for the industry, foodaily Expo 2022 (2022.05.31-06.02, Shanghai) is further upgraded. In addition to the upstream and downstream of the food industry, it also covers and gathers multiple resources such as e-commerce, social media, traffic, channels and capital, aiming to bring you an annual innovation feast. Here, products, content, technology, marketing and other aspects related to food & brand innovation will be presented in the form of “professional exhibition + innovative content + interactive experience”, breaking through and differentiating in the consistent form of industry exhibition.

food people are “watching”

Read the original text

Similar Posts

Leave a Reply

Your email address will not be published.